Iconovo
1,23 SEK
+2,94 %
Mindre end 1K følgere
ICO
First North Stockholm
Medical Equipment & Services
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
+2,94 %
-32,88 %
-42,76 %
-19,41 %
-67,32 %
-71,76 %
-97,31 %
-97,24 %
-96,24 %
Iconovo operates in the medical technology sector. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and coal, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and has its headquarters in Lund.
Læs mereMarkedsværdi
65 mio. SEK
Aktieomsætning
58,87 t SEK
Omsætning
2,93 mio.
EBIT %
-1.402,05 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning mio.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
15.12
2025
Ekstraordinær generalforsamling '25
27.2
2026
Årsrapport '25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Iconovo carries out a directed issue of shares of approx. SEK 25 million and a rights issue of shares of approx. SEK 24.6 million, which is covered to 100% by subscription undertakings and guarantee commitments
DNB Carnegie Access: Iconovo: New interim CEO appointed
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer